LD-2 disclosure · 1st Quarter - Report
ROCK & ASSOCIATES
Client
- Description
- Lobbying and government relations.
- Location
- District of Columbia · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Appropriations to fund the FDA implementation of compounding pharmacy regulations; H.R. 1625, Consolidated Appropriations Act, 2018.
LobbyistsSTEVE SYMMS · ROMANO ROMANI · mr THADDEUS E STROM
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
LobbyistsSTEVE SYMMS · ROMANO ROMANI · mr THADDEUS E STROM
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
LobbyistsSTEVE SYMMS · ROMANO ROMANI · mr THADDEUS E STROM
TargetedSENATE · HOUSE OF REPRESENTATIVES